VANGUARD GROUP INC - DIPEXIUM PHARMACEUTICALS INC ownership

DIPEXIUM PHARMACEUTICALS INC's ticker is DPRX and the CUSIP is 25456J104. A total of 19 filers reported holding DIPEXIUM PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of DIPEXIUM PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2017$150,000
-18.5%
114,9690.0%0.00%
Q4 2016$184,000
-92.7%
114,969
-33.7%
0.00%
Q3 2016$2,515,000
+60.3%
173,483
+9.6%
0.00%
Q2 2016$1,569,000
+13.3%
158,297
+8.7%
0.00%
Q1 2016$1,385,000
-10.2%
145,627
+5.7%
0.00%
Q4 2015$1,543,000
-99.0%
137,798
-97.0%
0.00%
-100.0%
Q3 2015$156,139,000
+13076.3%
4,594,100
+4830.2%
0.01%
Q2 2015$1,185,000
+66.9%
93,182
+79.0%
0.00%
Q1 2015$710,000
+69.5%
52,060
+41.5%
0.00%
Q4 2014$419,000
+47.5%
36,791
+28.7%
0.00%
Q3 2014$284,00028,5810.00%
Other shareholders
DIPEXIUM PHARMACEUTICALS INC shareholders Q1 2017
NameSharesValueWeighting ↓
Lone Star Value Management LLC 95,000$1,330,0002.54%
Timpani Capital Management LLC 134,716$1,886,0000.76%
KINGDON CAPITAL MANAGEMENT, L.L.C. 981,100$13,735,0000.66%
1492 Capital Management LLC 38,000$532,0000.38%
Broadfin Capital, LLC 465,978$6,524,0000.36%
Tourbillon Capital Partners, L.P. 785,615$10,999,0000.29%
ARDSLEY ADVISORY PARTNERS LP 45,000$630,0000.15%
683 Capital Management, LLC 70,000$980,0000.14%
BOOTHBAY FUND MANAGEMENT, LLC 18,043$253,0000.12%
FALCON POINT CAPITAL, LLC 22,570$316,0000.11%
View complete list of DIPEXIUM PHARMACEUTICALS INC shareholders